Phase II
A Phase 3, randomized, double-blind, placebo-controlled, multicenter, clinical trial with extension period to evaluate the efficacy and safety of Xeomin injections for the prevention of chronic migraine.
- Study HIC#:2000040105
- Last Updated:03/24/2026
- Age18 years and older
- GenderBoth
Contact Us
For more information about this study, including how to volunteer, contact:
Kelly Benson-Atwood
- Phone Number: 1-203-785-2445
Help Us Discover!
You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call +18779788343 for more information.
